Author

Takafumi Suda

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Serum GDF15 adds prognostic value to forced vital capacity in fibrotic interstitial lung disease.

BACKGROUND Antifibrotic therapy slows fibrotic interstitial lung disease (ILD) progression. However, fibrotic ILD remains a major life-threatening condition, with associated morbidity and mortality increasing annually. Growth differentiation factor 15 (GDF15), a stress-responsive cytokine within the transforming growth...

Yuzo Suzuki, Katsuhiro Yoshimura, K. Mori et al. · Respiratory Investigation · 0 citations

Open access Sep 2026

Incidence of and risk factors for immune checkpoint inhibitor–related pneumonitis in thoracic malignancies: a prospective multicenter study

Abstract Background Immune checkpoint inhibitors (ICIs) have fundamentally changed cancer treatment, but ICI-related pneumonitis (ICI-P) remains a major clinical concern. Although numerous studies have reported its incidence and risk factors, the retrospective nature of these studies makes accurate assessment difficult...

Yoshihiro Kitahara, Naoki Inui, Takafumi Koyauchi et al. · The Oncologist · 0 citations

Review Oct 2026

Species distribution and clinical significance of filamentous fungi detected from respiratory specimens before and after matrix-assisted laser desorption/ionization time-of-flight mass spectrometry implementation.

BACKGROUND The clinical significance of filamentous fungi detected from respiratory specimens uncertain in routine clinical practice, particularly for non-Aspergillus. We evaluated longitudinal species distribution and clinical correlates after implementation of MALDI-TOF MS. METHODS This single-center retrospective...

Kazuki Furuhashi, Sho Takuma, Osanori Nagura et al. · Journal of Infection and Che... · 0 citations